PHILADELPHIA — Philadelphia has seen its fair share of Risperdal lawsuits, many with conflicting rulings and award amounts.

The latest Philadelphia lawsuit that was going to trial settled just shortly before the jury was supposed to hear the case.

In the first Philadelphia Risperdal case, a jury found for the plaintiff and awarded him a $2.5 million verdict after finding that his abnormal breast development was the result of him taking the drug for an off-label use.

In the second Philadelphia Risperdal case, the jury also found that the Risperdal manufacturers failed to warn the plaintiff about the risks associated with the drug, but they ultimately awarded no monetary damages to the plaintiff because they were not convinced that the plaintiff’s breast development was the result of Risperdal use.

Now, 257 Risperdal cases in Philadelphia are being dismissed. According to the Pennsylvania state court judge, the cases were brought after the statute of limitations had already been reached, so they cannot be heard.

Essentially, the judge is saying that plaintiffs who took Risperdal and who experienced adverse effects in the 1990s should have linked them to the drug sooner than now when coverage of the effects have become more widespread.

Risperdal was originally approved by the United States Federal Drug Administration for use as an anti-psychotic medication. However, the lawsuits allege that its manufacturers, Johnson & Johnson and Janssen Pharmaceuticals, encouraged doctors to prescribe the drug for off-label use.

Risperdal has been linked to the development of gynecomastia, or abnormal breast development in males. The majority of the cases involve boys and teenagers who were prescribed Risperdal to treat autism or attention deficit disorder.

The Risperdal label was not modified to include a warning about gynecomastia until October of 2006, and the lawsuits allege that the manufacturers knew or should have known about the drug’s serious and often permanent side effects but that they still promoted the drug for off-label use.

The decision to dismiss these more than 250 cases still depends on the appellate court agreeing with the state judge’s analysis, and there at least one thousand other similar cases that are still pending in Philadelphia.

Our Lawyers Can Help

Our dangerous drug attorneys can help if you or someone you care about was harmed by Risperdal. Lawsuits have been filed against the drug maker by both patients and their families seeking compensation for injuries caused by this dangerous drug. You may be entitled to a settlement.We do not charge any legal fees unless you receive a settlement and we pay all of the case costs. If your claim is not successful for any reason, you do not owe us anything. We put it all in writing for you.

Our No Fee Promise on Risperdal Cases

You can afford to have our great team of lawyers on your side. When you choose us, it literally costs nothing to get started. We promise you in writing:

  • No money to get started
  • We pay all case costs and expenses
  • No legal fees whatsoever unless you receive a settlement
  • Phone calls are always free.

Start Your Risperdal Claim

Our lawyers will help you file your lawsuit. To get started, you can:

  1. Submit the Free Case Review Box on this page, or
  2. Call (866) 280-4722 any time of day to tell us about your case.

We will listen to your story and answer your questions. If you have claim, we will start immediately.

WARNING: There are strict time deadlines for filing lawsuit claims.